InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
stocktrademan Free
08/22/15 4:22 PM

Cortendo AB (publ) (CRTOF) RSS Feed

Followers
0
Posters
1
Posts (Today)
0
Posts (Total)
1
Created
08/22/15
Type
Free
Moderators
Cortendo AB (publ) Box 47 Partille, 433 21 Sweden Phone: 46 31 26 30 10 Fax: 46 31 26 30 10 Website: http://www.cortendo.com Cortendo AB (publ), a biopharmaceutical company, identifies, develops, and commercializes the treatments for orphan endocrine diseases in Europe and the United States. The company’s product pipeline includes COR-003 (levoketoconazole), which is in Phase III clinical trials for the treatment of endogenous Cushing’s syndrome. It is also developing COR-004, a second-generation antisense drug to treat acromegaly; and COR-005, a somatostatin ligand for metabolic stabilization of the peptides, as well as BioPancreate-2001, which is in pre-clinical trials for type 1 and 2 diabetes patients. Cortendo AB (publ) was founded in 1996 and is based in Partille, Sweden.
CRTOF Latest News
  • No Recent News Available for this company!
New Post